Oppenheimer Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,526
| Closed | -$597K | – | 1202 |
|
|
2025
Q1 | $597K | Buy |
13,526
+967
| +8% | +$42.7K | 0.01% | 809 |
|
|
2024
Q4 | $454K | Sell |
12,559
-837
| -6% | -$30.2K | 0.01% | 886 |
|
|
2024
Q3 | $429K | Sell |
13,396
-172
| -1% | -$5.51K | 0.01% | 913 |
|
|
2024
Q2 | $511K | Buy |
13,568
+3,892
| +40% | +$147K | 0.01% | 854 |
|
|
2024
Q1 | $476K | Sell |
9,676
-698
| -7% | -$34.4K | 0.01% | 848 |
|
|
2023
Q4 | $379K | Sell |
10,374
-1,267
| -11% | -$46.2K | 0.01% | 930 |
|
|
2023
Q3 | $269K | Sell |
11,641
-47
| -0.4% | -$1.09K | ﹤0.01% | 982 |
|
|
2023
Q2 | $306K | Buy |
+11,688
| New | +$306K | ﹤0.01% | 965 |
|
|
2022
Q4 | – | Sell |
-8,310
| Closed | -$237K | – | 1178 |
|
|
2022
Q3 | $237K | Sell |
8,310
-372
| -4% | -$10.6K | ﹤0.01% | 1012 |
|
|
2022
Q2 | $214K | Sell |
8,682
-225
| -3% | -$5.55K | ﹤0.01% | 1060 |
|
|
2022
Q1 | $503K | Buy |
8,907
+660
| +8% | +$37.3K | 0.01% | 915 |
|
|
2021
Q4 | $511K | Buy |
8,247
+3,302
| +67% | +$205K | 0.01% | 955 |
|
|
2021
Q3 | $314K | Buy |
+4,945
| New | +$314K | ﹤0.01% | 1047 |
|